328 related articles for article (PubMed ID: 25827834)
1. How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors.
Leissinger CA; Singleton T; Kruse-Jarres R
Blood; 2015 Jul; 126(2):153-9. PubMed ID: 25827834
[TBL] [Abstract][Full Text] [Related]
2. Prevention of bleeding in hemophilia patients with high-titer inhibitors.
Leissinger CA; Konkle BA; Antunes SV
Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074
[TBL] [Abstract][Full Text] [Related]
3. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction.
Leissinger CA
Am J Hematol; 2004 Oct; 77(2):187-93. PubMed ID: 15389908
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations.
Jiménez-Yuste V; Alvarez MT; Martín-Salces M; Quintana M; Rodriguez-Merchan C; Lopez-Cabarcos C; Velasco F; Hernández-Navarro F
Haemophilia; 2009 Jan; 15(1):203-9. PubMed ID: 19149850
[TBL] [Abstract][Full Text] [Related]
5. Some recent developments regarding arthropathy and inhibitors in haemophilia.
Rodriguez-Merchan EC
Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189
[TBL] [Abstract][Full Text] [Related]
6. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
[TBL] [Abstract][Full Text] [Related]
7. Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Oldenburg J; Mahlangu JN; Kim B; Schmitt C; Callaghan MU; Young G; Santagostino E; Kruse-Jarres R; Negrier C; Kessler C; Valente N; Asikanius E; Levy GG; Windyga J; Shima M
N Engl J Med; 2017 Aug; 377(9):809-818. PubMed ID: 28691557
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis in haemophilia patients with inhibitors.
Leissinger CA
Haemophilia; 2006 Dec; 12 Suppl 6():67-72; discussion 72-3. PubMed ID: 17123397
[TBL] [Abstract][Full Text] [Related]
9. Long-term FEIBA prophylaxis does not prevent progression of existing joint disease.
Hilgartner MW; Makipernaa A; Dimichele DM
Haemophilia; 2003 May; 9(3):261-8. PubMed ID: 12694515
[TBL] [Abstract][Full Text] [Related]
10. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Stobart K; Iorio A; Wu JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
[TBL] [Abstract][Full Text] [Related]
11. Experiences in the prevention of arthropathy in haemophila patients with inhibitors.
Jimenez-Yuste V; Rodriguez-Merchan EC; Alvarez MT; Quintana M; Martin-Salces M; Hernandez-Navarro F
Haemophilia; 2008 Nov; 14 Suppl 6():28-35. PubMed ID: 19134031
[TBL] [Abstract][Full Text] [Related]
12. Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors.
Ewenstein BM; Wong WY; Schoppmann A
Haemophilia; 2010 Jan; 16(1):179-80. PubMed ID: 19702885
[No Abstract] [Full Text] [Related]
13. When should prophylaxis therapy in inhibitor patients be considered?
Young G; Auerswald G; Jimenez-Yuste V; Konkle BA; Lambert T; Morfini M; Santagostino E; Blanchette V
Haemophilia; 2011 Sep; 17(5):e849-57. PubMed ID: 21418444
[TBL] [Abstract][Full Text] [Related]
14. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK
Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684
[TBL] [Abstract][Full Text] [Related]
15. Management of factor VIII inhibitors.
Acharya SS; DiMichele DM
Best Pract Res Clin Haematol; 2006; 19(1):51-66. PubMed ID: 16377541
[TBL] [Abstract][Full Text] [Related]
16. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Stobart K; Iorio A; Wu JK
Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors.
Antunes SV; Tangada S; Stasyshyn O; Mamonov V; Phillips J; Guzman-Becerra N; Grigorian A; Ewenstein B; Wong WY
Haemophilia; 2014 Jan; 20(1):65-72. PubMed ID: 23910578
[TBL] [Abstract][Full Text] [Related]
18. Prevention of haemophilic arthropathy in haemophilic children with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2008 Nov; 14 Suppl 6():1-3. PubMed ID: 19134025
[TBL] [Abstract][Full Text] [Related]
19. Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series.
Ettingshausen CE; Kreuz W
Haemophilia; 2010 Jan; 16(1):90-100. PubMed ID: 19878335
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis in haemophilia with inhibitors: update from international experience.
Carcao M; Lambert T
Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
